Crisis-resistant generic
Generic drug manufacturers hope to use the global economic crisis to expand their business. They have market conditions, public opinion and political will on their side in most countries of the world.
08.12.2008Generic drug manufacturers hope to use the global economic crisis to expand their business. They have market conditions, public opinion and political will on their side in most countries of the world.
08.12.2008According to experts' forecasts, the collapse risks are low for systemically important drug suppliers and leading domestic manufacturers. The financial crisis may stimulate the renewal of the pharmaceutical market, as in 1998.
13.11.2008Seth Rosenblat, Vice President of Marketing at Interwoven, warns website owners against gluttony, envy, fornication, pride, greed, laziness and anger. They lead to the fact that visitors will not visit your resource and buy your products, and they will not want to deal with your company at all.
29.10.2008The main advantages of the biopharmaceutical market are the rapid and efficient development of production capacities, the development of effective drugs, and the active expansion of such segments as bioinformatics and diagnostics.
17.10.2008The last refuge of free capital is private equity funds. They will not be able to finance all companies, but they can launch the process of mergers and acquisitions in many sectors.
13.10.2008There is still no miracle cure that could make employees happy. But there are things that can create an environment in which people will thrive.
02.09.2008A curious research project is under consideration at the Eternal Youth Foundation. The data obtained by the author as a result of previous studies supported by the RFBR grant allow us to count on the development of ways to treat mitochondrial encephalomyopathies and slow down and even prevent the aging processes of cells induced by damage to their active oxygen forms by activating the growth of protomitochondria, as well as the elimination of old mitochondrial organelles – postmitochondria.
11.07.2008Fortune magazine included GlaxoSmithKline, one of the world's largest pharmaceutical companies intensively engaged in the development and production of biotechnological drugs, and one Russian company in the top five in terms of investment attractiveness for next year: (true, it has nothing to do with biotech and biopharma):
11.07.2008The statistics of the Russian IPO market show that the shares of most companies fall in price after the initial public offering. Meanwhile, in the process of preparing for the IPO, issuers are restructuring, becoming transparent, and their value is growing rapidly. To participate in the growth that precedes the placement of shares, so-called pre-IPO funds are used.
11.07.2008Competition from generic drugs (copies of original drugs) will lead to a reduction in sales of the largest American companies by $67 billion already in 2007-2012, as patent protection for more than 30 drugs will expire. This is almost half of the total revenue of US companies in 2007. Looking at all this, financial analysts do not recommend investing in the securities of pharmaceutical companies. Experts predict the leadership of biotechnologies, in which generics are technologically and legally impossible.
11.07.2008Based on the new realities, it is necessary to follow a fundamentally different investment tactic, different from everything that has been practiced in recent years, says Jonathan Burton. On behalf of MarketWatch, they compiled 10 tips for investors where to direct their money in the next 12 months, so that later it would not be excruciatingly painful for senseless investments.
11.07.2008A small addition of substances present in any living cell – nicotinamide dinucleotide (NADH) and adenosine triphosphoric acid (ATP), as well as some harmless dicarboxylic acids – allow you to store ground sausage without spoilage for several weeks, and sausage instead of ten – forty, and not add poisonous nitrates and nitrites to them. But do industrialists accept safer technologies?
11.07.2008Which way should a manager choose – to demonstrate closeness to subordinates or to introduce strict subordination? To what extent and in what way should the doors be "opened" in order to avoid the disadvantages and take advantage of the advantages of such a management style?
11.07.2008From the point of view of business, demonopolization and the involvement of additional state-authorized experts will only benefit, since it will allow more new immunobiological drugs to be brought to the end user faster. The new order is more convenient for everyone, except those who have lost their monopoly.
11.07.2008Despite a slight slowdown in growth this year, the global pharmaceutical market is in excellent condition and on the verge of major changes.
11.07.2008Information technologies certainly increase the effectiveness of treatment. Buyers of medical services (those who pay for them) express concern about the need to finance technological developments, since medical technologies, such as effective diagnosis of diseases at early stages, can lead to an increase in the effectiveness of treatment.
27.06.2008One of the highest paid categories of managers in the pharmaceutical industry is the heads of marketing departments, starting salaries reach 120-160 thousand rubles.
25.06.2008What does a network user want from medical sites? Why are medical websites "not working"? What should they be like for a visitor to want to use them?
15.05.2008The head of GlaxoSmithKline, resigning, at parting recommends that Big Pharma companies radically change their approach to research and development and drastically reduce advertising costs.
13.05.2008The Seven Rules of doing business from Bernardo Provenzano, the "boss of bosses" of Cosa Nostra.
07.05.2008You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.